Clinical and Economic Burdens of ADHD Across Developmental Stages: A Review
Journal of Clinical Medicine · 06.11.2026 · 15 (21) · 8645
DOI: 10.3390/jcm15218645 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.11.2026. Verfasst von Farzad Salehpour und 1 weiteren Autor:innen. Beteiligte Einrichtung: Texas Consortium in Behavioral Neuroscience, Department of Psychology, The University of Texas at Austin, Austin, TX 78712, USA. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oskar Fischer Project, Elhapa Foundation.
Abstract (Originalsprache)
Background
Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder that can persist across the lifespan and is associated with substantial clinical, economic, and psychosocial burden. This narrative review examines the clinical and economic burdens of ADHD on individuals and families, encompassing direct medical costs, including assessment and treatment expenditures, alongside non-medical costs, educational and occupational disruption, caregiving demands, and adverse mental health outcomes among family members. It synthesizes evidence across developmental stages and geographic regions and considers the clinical implications of these interconnected burdens.
Methods
A structured search of PubMed, Scopus, Web of Science, and Embase, supplemented by reference-list screening, identified English-language publications from January 2000 through June 2026. Evidence was synthesized narratively across direct medical, non-medical, and family-related burdens, prioritizing large population-based and administrative claims studies, longitudinal investigations, systematic reviews, and meta-analyses. Interpretation considered study design, confounding factors, economic perspectives, and differences in cost estimation.
Results
ADHD is associated with substantial healthcare, non-medical, and family-related economic costs. Reported costs encompass diagnostic assessment, treatment, comorbidity, and adverse events, alongside educational support, occupational losses, accidents, and criminal justice involvement. Families experience reduced occupational productivity, elevated caregiving demands, greater healthcare utilization, and increased depression, anxiety, and stress.
Conclusions
Clinically, these findings support assessing functional and family-level burden alongside symptoms, identifying and managing comorbidities, maintaining treatment during transitions to adult services, and monitoring tolerability. Integrating these burden domains into routine assessment and treatment planning may help identify modifiable drivers of impairment and guide more comprehensive care across the lifespan for patients and their families.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Texas Consortium in Behavioral Neuroscience, Department of Psychology, The University of Texas at Austin, Austin, TX 78712, USA.
- Interdisciplinary Neuroscience Program, Department of Psychiatry and Behavioral Sciences, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
ORCID-Profile: Farzad Salehpour, Francisco Gonzalez-Lima
Förderung
- Oskar Fischer Project
- Elhapa Foundation
Zitieren
APA
Salehpour, F., & Gonzalez-Lima, F. (2026). Clinical and Economic Burdens of ADHD Across Developmental Stages: A Review. Journal of Clinical Medicine, 15(21), 8645. https://doi.org/10.3390/jcm15218645
Vancouver
Salehpour F, Gonzalez-Lima F. Clinical and Economic Burdens of ADHD Across Developmental Stages: A Review. Journal of Clinical Medicine. 2026;15(21):8645. doi:10.3390/jcm15218645
BibTeX
@article{Salehpour2026,
author = {Salehpour, Farzad and Gonzalez-Lima, Francisco},
title = {Clinical and Economic Burdens of ADHD Across Developmental Stages: A Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8645},
doi = {10.3390/jcm15218645}
}
EUVIMED